Healthcare & Life Sciences
RetroSense Therapeutics, LLC
United Stateswww.reuters.com/article/idUSFWN1BI02Q
series-b
series-b
Stage
1
Investors
About
RetroSense Therapeutics is developing gene therapies that restore vision in patients with retinal degenerative diseases by using optogenetic technology.
Explore RetroSense Therapeutics, LLC's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.